Patents by Inventor Kentaro Furumoto

Kentaro Furumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION COMPRISING TETRACYCLIC COMPOUND
    Publication number: 20230398096
    Abstract: A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid. is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
    Type: Application
    Filed: December 14, 2022
    Publication date: December 14, 2023
    Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Kentaro FURUMOTO, Koji SHIRAKI, Tomoaki HIRAYAMA
  • COMPOSITION COMPRISING TETRACYCLIC COMPOUND
    Publication number: 20210052550
    Abstract: A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid.is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
    Type: Application
    Filed: April 7, 2020
    Publication date: February 25, 2021
    Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Kentaro FURUMOTO, Koji SHIRAKI, Tomoaki HIRAYAMA
  • Composition comprising tetracyclic compound
    Patent number: 10646468
    Abstract: A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid.is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: May 12, 2020
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Kentaro Furumoto, Koji Shiraki, Tomoaki Hirayama
  • COMPOSITION COMPRISING TETRACYCLIC COMPOUND
    Publication number: 20160317494
    Abstract: A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid.is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
    Type: Application
    Filed: May 11, 2016
    Publication date: November 3, 2016
    Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: KENTARO FURUMOTO, KOJI SHIRAKI, TOMOAKI HIRAYAMA
  • Composition comprising tetracyclic compound
    Patent number: 9365514
    Abstract: A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: June 14, 2016
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Kentaro Furumoto, Koji Shiraki, Tomoaki Hirayama
  • COMPOSITION COMPRISING TETRACYCLIC COMPOUND
    Publication number: 20130143877
    Abstract: A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid. is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
    Type: Application
    Filed: August 19, 2011
    Publication date: June 6, 2013
    Inventors: Kentaro Furumoto, Koji Shiraki, Tomoaki Hirayama